# Vasoreactivity in Carriers of Genetic Polymorphisms

> **NCT00160888** · PHASE1 · UNKNOWN · sponsor: **Heidelberg University** · enrollment: 100 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** sodium nitroprusside, bradykinin, acetylcholine

## Key facts

- **NCT ID:** NCT00160888
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 1999-11
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 100 (—)
- **Last updated:** 2005-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00160888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00160888, "Vasoreactivity in Carriers of Genetic Polymorphisms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00160888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*